NCT06699316Active, not recruiting
Prognostic Counselling in Palliative Head and Neck Cancer (ProCoPall)
Individualized Prognostic Counseling on Life Expectancy of Head and Neck Cancer Patients in the Palliative Phase
Source: ClinicalTrials.gov · Last updated 21 Nov 2024
Brief summary (registry, in English)
The investigators test the effect of providing individualized prognostic information on life-expectancy to head and neck cancer patients in the palliative phase.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 25 Oct 2024
- Start date
- 1 Sept 2022
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Erasmus Medical Center
- Diseases
- Head and neck cancer
- NCT number
- NCT06699316
What you commit to
- Study type: Interventional
- Planned participants: 160
- From 1 Sept 2022 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Illiterate patients
- Insufficient knowledge of Dutch language
- Incompetent (due to i.e. mental state) to consider their own treatment choice
Who the study is looking for
- Patients who received a palliative diagnosis of a squamous cell carcinoma of the oral cavity, oropharynx, nasopharynx, hypopharynx, supraglottic larynx, glottis larynx and unknown primary.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erasmus MC Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.